An FDA import alert on coconut means US ports may hold a listed firm’s shipments without opening or sampling them first. The practical effect is that the buyer, not the agency, must prove each container is clean. FDA calls this detention without physical examination, or DWPE, and the coconut alert is Import Alert 23-12.
For a US procurement manager the cost is concrete: a container sitting on a terminal accrues demurrage and storage while a laboratory report is commissioned. A supplier on the list turns every lot into a testing project. A supplier off the list does not.
What is Import Alert 23-12?
Import Alert 23-12 is titled “Detention Without Physical Examination of Coconut Due to the Presence of Microbiological Contamination”. Its latest published version is dated 17 July 2025, and FDA’s own alert page is the only reliable source for which firms and products are on it today.
The alert dates from a 1991 cholera outbreak traced to a dessert made with coconut milk. FDA found toxigenic Vibrio cholerae and Salmonella in frozen coconut milk. In 2008 a sample of shredded coconut from India tested positive for Listeria monocytogenes. Those findings set the three organisms the alert still names.
Two points on scope matter for buyers. The alert operates through a “Red List” of named firms, so it is a supplier-level restriction, not a ban on a country or a product category. And it works alongside broader alerts, such as the Salmonella alert for food products (99-19), which can apply to a coconut item from a firm that has no 23-12 listing.
What does DWPE change at the port?
DWPE reverses the normal sequence. Ordinarily FDA examines or samples a shipment and detains it if something looks wrong. Under an alert, the shipment is detained on arrival because the firm is listed, and it stays detained until the importer supplies evidence.
| Step | Normal entry | Entry under a DWPE listing |
|---|---|---|
| Who starts | FDA selects a line for review or sampling | Detention is automatic for the listed firm |
| Burden | FDA must find an apparent violation | Importer must show the lot is not contaminated |
| Evidence | FDA’s own sample result | Importer’s laboratory report, plus FDA audit sampling if it chooses |
| Typical delay | Days, if reviewed at all | Weeks, until the report is filed and accepted |
The detention is communicated through a Notice of FDA Action. FDA’s detention and hearing page explains that the notice also serves as the notice of hearing, so the importer has a limited window to respond. Read the “respond by” date on the notice the day it arrives, because a missed date can end in refusal.
How does a detained coconut shipment get released?
A single lot is released by evidence, not by argument. Alert 23-12 says the owner, consignee or other responsible party should provide evidence that the product does not contain the microbiological contamination, and names private laboratory analysis of a representative sample as one form.
The testing rule tightened recently. From 2 December 2025, Listeria testing offered in support of admission must come from a laboratory accredited under FDA’s Laboratory Accreditation for Analyses of Foods programme, known as LAAF (21 CFR 1.1107). A report from an unaccredited lab, however well run, will not carry a Listeria question.
Even with a clean report, FDA may collect its own audit sample before deciding. Build that into the schedule. A buyer who books the reefer pick-up for the day the report lands is assuming a decision FDA has not made.
If the product cannot be cleared, the shipment is refused. FDA’s import refusals guidance states that a refused shipment must be exported or destroyed under CBP and FDA supervision within 90 days of the refusal notice. Reconditioning is possible only where FDA policy allows the proposed operation, and the compliance officer named on the notice decides that.
How does a firm get taken off the Red List?
Release of one shipment does not touch the listing. Removal needs a separate petition showing the firm has fixed the cause. The alert tells petitioners to send supporting information to FDA’s import alerts mailbox, and FDA’s removal guidance says no form is required and a separate petition is needed for each alert the firm appears on.
The usual evidence package has two parts. First, a root-cause investigation and corrective actions at the plant. Second, entry documentation for a run of compliant shipments. FDA lists failure to submit documents for five consecutive compliant shipments as a common reason petitions are denied, and splitting one large lot into several small ones to reach the count is another.
That second part has a commercial consequence. While a supplier is listed, every compliant lot it ships to the US costs the importer a hold, a test and a delay. Few buyers will fund five of them to rebuild a supplier’s record. In practice the supplier’s own credibility, and a willingness to carry the testing cost, decides whether the petition ever gets built.
What should a buyer check before the shipment sails?
Screen the supplier against the live alert pages before the purchase order, not after the notice. FDA publishes the Red List on the alert itself, and it changes without press releases. A quarterly check is too slow for a programme that ships monthly.
A supplier with a documented pathogen control step is the better defence. Our note on the Salmonella kill step in desiccated coconut sets out what validation should look like, and the guide to reading a desiccated coconut COA covers which microbiological lines to demand per lot. The importer’s own verification file, described in our piece on FSVP records for coconut imports, is the document an FDA officer will ask for first.
What this means for buyers
- Procurement managers (persona A): add an import alert screen to supplier approval and to each purchase order, and write the right to reject listed-firm cargo into the contract.
- Importers and distributors: price a detention scenario into the landed cost, including terminal storage and a LAAF-accredited laboratory fee, and agree in advance who carries it.
- Brand owners: a co-packer’s ingredient supplier appearing on a Red List is your problem too, because the recall and the retailer call land on your brand.
- Traders and brokers: a listed origin firm trades at a discount for a reason. Do not quote it into the US without a clause that returns the testing and demurrage cost to the seller.
FAQ
Does an import alert ban a country’s coconut from the US? No. Alert 23-12 lists named firms. Other firms in the same country enter under normal procedures, although FDA may still sample them.
Can a detained container be released with a private laboratory report? Yes, FDA names private laboratory analysis as acceptable evidence. Listeria testing must now come from a LAAF-accredited laboratory, and FDA may still take its own audit sample.
How long does a refused container have? Ninety days from the date of the refusal notice to export or destroy it, under CBP and FDA supervision. FDA says it cannot extend that period.
How does a supplier get off the list? It petitions FDA with evidence that the cause is fixed, usually including documentation for five consecutive compliant shipments. A separate petition is needed per alert.
Need a supplier with a clean US entry record and a documented kill step? Send the desk an RFQ and name the destination port.